10-Q Filing

AIM IMMUNOTECH INC. CIK: 946644 Q1 2022

Filing Information

Form Type	10-Q
Accession Number	`0001493152-22-013341`
Period End Date	20220331
Filing Date	20220513
Fiscal Year	2022
Fiscal Period	Q1
XBRL Instance	form10-q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 60 Income Statement 34 Cash Flow Statement 57 Stockholders Equity 14

Balance Sheet 60 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$28.99M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$32.09M	USD	Point-in-time
Marketable securities	`DebtSecurities`	$15.55M	USD	Point-in-time
Marketable securities	`DebtSecurities`	$16.18M	USD	Point-in-time
Funds receivable from New Jersey net operating loss	`AccountsReceivableRelatedPartiesCurrent`	$1.64M	USD	Point-in-time
Funds receivable from New Jersey net operating loss	`AccountsReceivableRelatedPartiesCurrent`	$1.64M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$296.00K	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$304.00K	USD	Point-in-time
Assets held for sale	`AssetsHeldForSaleNotPartOfDisposalGroupCurrent`	$3.90M	USD	Point-in-time
Assets held for sale	`AssetsHeldForSaleNotPartOfDisposalGroupCurrent`	-	USD	Point-in-time
Total current assets	`AssetsCurrent`	$50.21M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$50.38M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$137.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.05M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$144.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$149.00K	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$1.99M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$1.97M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$1.50M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	47.99M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	47.99M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	47.99M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	47.99M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.51M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.32M	USD	Point-in-time
Total assets	`Assets`	$57.70M	USD	Point-in-time
Total assets	`Assets`	$54.16M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$198.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$378.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$438.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$328.00K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$37.00K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$60.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$673.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$766.00K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$84.00K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$112.00K	USD	Point-in-time
Redeemable warrants	`RedeemableWarrants`	$35.00K	USD	Point-in-time
Redeemable warrants	`RedeemableWarrants`	$4.00K	USD	Point-in-time
Commitments and contingencies (Notes 12, 13 and 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Notes 12, 13 and 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Series B Convertible Preferred Stock, stated value $1,000 per share, 715 issued and outstanding	`PreferredStockValue`	$715.00K	USD	Point-in-time
Series B Convertible Preferred Stock, stated value $1,000 per share, 715 issued and outstanding	`PreferredStockValue`	$715.00K	USD	Point-in-time
Common Stock, par value $0.001 per share, authorized 350,000,000 shares; 47,994,672 issued and outstanding	`CommonStockValue`	$48.00K	USD	Point-in-time
Common Stock, par value $0.001 per share, authorized 350,000,000 shares; 47,994,672 issued and outstanding	`CommonStockValue`	$48.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$417.46M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$417.22M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-364.92M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-361.10M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$56.88M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$61.29M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$70.97M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$53.30M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$57.70M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$54.16M	USD	Point-in-time

Income Statement 34 line items

Line Item	Tag	Value	Unit	Period
Total Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$28.00K	USD	1 Quarter
Total Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$33.00K	USD	1 Quarter
Production costs	`ManufacturingCosts`	$77.00K	USD	1 Quarter
Production costs	`ManufacturingCosts`	$237.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.42M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.04M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.11M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.07M	USD	1 Quarter
Total Costs and Expenses	`CostsAndExpenses`	$3.77M	USD	1 Quarter
Total Costs and Expenses	`CostsAndExpenses`	$3.19M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-3.75M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-3.15M	USD	1 Quarter
(Loss) on investments	`GainLossOnInvestments`	$-934.00K	USD	1 Quarter
(Loss) on investments	`GainLossOnInvestments`	-	USD	1 Quarter
Interest and other income	`InterestAndOtherIncome`	$72.00K	USD	1 Quarter
Interest and other income	`InterestAndOtherIncome`	$45.00K	USD	1 Quarter
Interest expense and other finance costs	`InterestExpense`	$50.00K	USD	1 Quarter
Interest expense and other finance costs	`InterestExpense`	-	USD	1 Quarter
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$37.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-31.00K	USD	1 Quarter
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLoss`	$-181.00K	USD	1 Quarter
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLoss`	$-190.00K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-3.82M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-3.58M	USD	1 Quarter
Reclassification adjustment for realized investment loss	`ReclassificationAdjustmentForRealizedInvestmentLost`	$2.00K	USD	1 Quarter
Reclassification adjustment for realized investment loss	`ReclassificationAdjustmentForRealizedInvestmentLost`	-	USD	1 Quarter
Change in unrealized loss on marketable securities available for sale	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	1 Quarter
Change in unrealized loss on marketable securities available for sale	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-163.00K	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.74M	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.82M	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasic`	$-0.08	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasic`	$-0.08	USD	1 Quarter
Weighted average shares outstanding basic and diluted	`WeightedAverageNumberOfSharesIssuedBasic`	45.73M	shares	1 Quarter
Weighted average shares outstanding basic and diluted	`WeightedAverageNumberOfSharesIssuedBasic`	47.99M	shares	1 Quarter

Cash Flow Statement 57 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-3.82M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.58M	USD	1 Quarter
Depreciation of property and equipment	`Depreciation`	$10.00K	USD	1 Quarter
Depreciation of property and equipment	`Depreciation`	$162.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`RedeemableWarrantsValuationAdjustment`	$37.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`RedeemableWarrantsValuationAdjustment`	$-31.00K	USD	1 Quarter
Amortization of patent, trademark rights	`AmortizationOfIntangibleAssets`	$116.00K	USD	Annual
Amortization of patent, trademark rights	`AmortizationOfIntangibleAssets`	$65.00K	USD	1 Quarter
Amortization of patent, trademark rights	`AmortizationOfIntangibleAssets`	$19.00K	USD	1 Quarter
Changes in ROU assets	`IncreaseDecreaseinRightofUseAssets`	$5.00K	USD	1 Quarter
Changes in ROU assets	`IncreaseDecreaseinRightofUseAssets`	$11.00K	USD	1 Quarter
Loss on available for sale marketable securities	`MarketableSecuritiesGainLoss`	$-19.00K	USD	1 Quarter
Loss on available for sale marketable securities	`MarketableSecuritiesGainLoss`	$-2.00K	USD	1 Quarter
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLosses`	$-190.00K	USD	1 Quarter
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLosses`	$-181.00K	USD	1 Quarter
Equity-based compensation	`ShareBasedCompensation`	$242.00K	USD	1 Quarter
Equity-based compensation	`ShareBasedCompensation`	$526.00K	USD	1 Quarter
Unrealized loss on marketable securities	`DebtSecuritiesAvailableForSaleGainLoss`	$-915.00K	USD	1 Quarter
Unrealized loss on marketable securities	`DebtSecuritiesAvailableForSaleGainLoss`	-	USD	1 Quarter
Amortization of finance and debt issuance costs	`AmortizationOfFinancingCosts`	-	USD	1 Quarter
Amortization of finance and debt issuance costs	`AmortizationOfFinancingCosts`	$36.00K	USD	1 Quarter
Prepaid expenses and other current assets and other non current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-8.00K	USD	1 Quarter
Prepaid expenses and other current assets and other non current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-26.00K	USD	1 Quarter
Lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-5.00K	USD	1 Quarter
Lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-11.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$180.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-194.00K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$55.00K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-110.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.76M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.04M	USD	1 Quarter
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$2.04M	USD	1 Quarter
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$407.00K	USD	1 Quarter
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$1.15M	USD	1 Quarter
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$720.00K	USD	1 Quarter
Purchase of patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$365.00K	USD	1 Quarter
Purchase of patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$33.00K	USD	1 Quarter
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$523.00K	USD	1 Quarter
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-346.00K	USD	1 Quarter
Financing obligation payments	`RepaymentsOfLongTermDebt`	$93.00K	USD	1 Quarter
Financing obligation payments	`RepaymentsOfLongTermDebt`	-	USD	1 Quarter
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$12.89M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$12.79M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	1 Quarter
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$10.27M	USD	1 Quarter
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-3.10M	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$32.09M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$48.77M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$28.99M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$38.50M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$32.09M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$48.77M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$28.99M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$38.50M	USD	Point-in-time
Conversion of Series B preferred	`ConversionOfSeriesBPreferred`	-	USD	1 Quarter
Conversion of Series B preferred	`ConversionOfSeriesBPreferred`	$7.00K	USD	1 Quarter

Stockholders Equity 14 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$56.88M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$61.29M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$70.97M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$53.30M	USD	Point-in-time
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$242.00K	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$526.00K	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.74M	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.82M	USD	1 Quarter
Common Stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$12.89M	USD	1 Quarter
Series B preferred shares converted to Common shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	1 Quarter
Ending balance, value	`StockholdersEquity`	$56.88M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$61.29M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$70.97M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$53.30M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.